Pubblicazioni

Native T1 and T2 provide distinctive signatures in hypertrophic cardiac conditions â Comparison of uremic, hypertensive and hypertrophic cardiomyopathy

2020 - INTERNATIONAL JOURNAL OF CARDIOLOGY

Arcari, L.; Hinojar, R.; Engel, J.; Freiwald, T.; Platschek, S.; Zainal, H.; Zhou, H.; Vasquez, M.; Keller, T.; Rolf, A.; Geiger, H.; Hauser, I.; Vogl, T. J.; Zeiher, A. M.; Volpe, M.; Nagel, E.; Puntmann, V. O.

Interferon lambda 4 rs368234815 TT>Î´G variant is associated with liver damage in patients with nonalcoholic fatty liver disease.

2017 - HEPATOLOGY

Petta, S; Valenti, Laura; Tuttolomondo, A; Dongiovanni, P; Pipitone, Rm; CammÃ , C; Cabibi, D; Di Marco, V; Fracanzani, Al; Badiali, S; Nobili, V; Fargion, S; Grimaudo, S; CraxÃ¬, A.

Pubblicazioni

Native T1 and T2 provide distinctive signatures in hypertrophic cardiac conditions â Comparison of uremic, hypertensive and hypertrophic cardiomyopathy

Interferon lambda 4 rs368234815 TT&gt;Î´G variant is associated with liver damage in patients with nonalcoholic fatty liver disease.

Native T1 and T2 provide distinctive signatures in hypertrophic cardiac conditions â Comparison of uremic, hypertensive and hypertrophic cardiomyopathy

Interferon lambda 4 rs368234815 TT>Î´G variant is associated with liver damage in patients with nonalcoholic fatty liver disease.